The Lack of Correlation Between Experimental Metastatic Potential and Platelet Aggregating Activity of B16 Melanoma Clones Viewed in Relation to Tumor Cell Heterogeneity

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 1987 Apr 1

PMID 3594970

Citations 7

Authors

A K Kimura

P Mehta

J H Xiang

D Lawson

D Dugger

K J Kao

Affiliations

Soon will be listed here.

Abstract

Two widely used B16 melanoma cell lines of low and high lung colonizing potential (B16-F1 and B16-F10) were compared in their ability to induce platelet aggregation. The results of these experiments showed a reproducible difference in platelet aggregating activity of these two cell lines which directly correlated with their lung colonizing potentials. However, when clones were derived from these heterogeneous cell lines and tested for experimental metastatic potential, platelet aggregating ability and Met-72 expression, no correlation could be attached to the platelet aggregating activity of the clones. Results of these experiments provide direct evidence that platelet aggregation is not an accurate index of experimental metastatic potential of tumor cell clones, nor is it an essential trait of all metastatic cells. The ability of tumor cells to induce platelet aggregation is examined and discussed in the context of cellular heterogeneity.

Citing Articles

Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasis.

Kirstein J, Hague M, McGowan P, Tuck A, Chambers A J Mol Med (Berl). 2016; 94(8):899-910.

PMID: 27048169 DOI: 10.1007/s00109-016-1415-2.

Synthesis and expression of metastasis-associated, Met-72/83 antigens.

Xiang J, Kimura A, Hansen J Clin Exp Metastasis. 1988; 6(6):473-83.

PMID: 3409561 DOI: 10.1007/BF01784378.

Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Nicolson G Cancer Metastasis Rev. 1988; 7(2):143-88.

PMID: 3293836 DOI: 10.1007/BF00046483.

Antimetastatic action of the prostacyclin analog iloprost in the mouse.

Sava G, Perissin L, Zorzet S, Piccini P, Giraldi T Clin Exp Metastasis. 1989; 7(6):671-8.

PMID: 2476273 DOI: 10.1007/BF01753677.

Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.

WEISS L, Orr F, Honn K Clin Exp Metastasis. 1989; 7(2):127-67.

PMID: 2465861 DOI: 10.1007/BF01787020.

References

Nicolson G . Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim Biophys Acta. 1982; 695(2):113-76. DOI: 10.1016/0304-419x(82)90020-8. View

Roos E, Dingemans K . Mechanisms of metastasis. Biochim Biophys Acta. 1979; 560(1):135-66. DOI: 10.1016/0304-419x(79)90005-2. View

Karpatkin S, Pearlstein E . Role of platelets in tumor cell metastases. Ann Intern Med. 1981; 95(5):636-41. DOI: 10.7326/0003-4819-95-5-636. View

Hilgard P, Thornes R . Anticoagulants in the treatment of cancer. Eur J Cancer (1965). 1976; 12(10):755-62. DOI: 10.1016/0014-2964(76)90088-8. View

Chew E, Wallace A . Demonstration of fibrin in early stages of experimental metastases. Cancer Res. 1976; 36(6):1904-9. View

Xiang J, Kimura A . In vitro modulation of the metastatic phenotype. I. Analysis of differentiation forms of the B16 melanoma expressing Met-72 determinants and metastatic activity. Clin Exp Metastasis. 1986; 4(4):293-309. DOI: 10.1007/BF00133594. View

Gasic G, Gasic T, Galanti N, Johnson T, Murphy S . Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer. 1973; 11(3):704-18. DOI: 10.1002/ijc.2910110322. View

Pearlstein E, Salk P, Yogeeswaran G, Karpatkin S . Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Proc Natl Acad Sci U S A. 1980; 77(7):4336-9. PMC: 349829. DOI: 10.1073/pnas.77.7.4336. View

Fidler I . Selection of successive tumour lines for metastasis. Nat New Biol. 1973; 242(118):148-9. DOI: 10.1038/newbio242148a0. View

10.

Liotta L, Saidel M, KLEINERMAN J . The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res. 1976; 36(3):889-94. View

11.

Xiang J, Kimura A . Isolation of metastatic B16 melanoma variants using anti-Met 72 monoclonal antibodies and flow cytometry. Clin Exp Metastasis. 1987; 5(1):35-42. DOI: 10.1007/BF00116624. View

12.

Tsuruo T, Kawabata H, Iida H, Yamori T . Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis. Clin Exp Metastasis. 1986; 4(1):25-33. DOI: 10.1007/BF00053470. View

13.

Estrada J, Nicolson G . Tumor-cell-platelet aggregation does not correlate with metastatic potential of rat 13762NF mammary adenocarcinoma tumor cell clones. Int J Cancer. 1984; 34(1):101-5. DOI: 10.1002/ijc.2910340118. View

14.

Hilgard P . The role of blood platelets in experimental metastases. Br J Cancer. 1973; 28(5):429-35. PMC: 2008922. DOI: 10.1038/bjc.1973.168. View

15.

Kimura A, Xiang J . High levels of Met-72 antigen expression: correlation with metastatic activity of B16 melanoma tumor cell variants. J Natl Cancer Inst. 1986; 76(6):1247-54. View

16.

Al-Mondhiry H . Tumor interaction with hemostasis: the rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer. Am J Hematol. 1984; 16(2):193-202. DOI: 10.1002/ajh.2830160213. View

17.

Fidler I, Gersten D, Hart I . The biology of cancer invasion and metastasis. Adv Cancer Res. 1978; 28:149-250. DOI: 10.1016/s0065-230x(08)60648-x. View

18.

Nicolson G, Poste G . Tumor cell diversity and host responses in cancer metastasis--part I--properties of metastatic cells. Curr Probl Cancer. 1982; 7(6):1-83. DOI: 10.1016/s0147-0272(82)80017-2. View

19.

Gasic G, Gasic T, Stewart C . Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A. 1968; 61(1):46-52. PMC: 285903. DOI: 10.1073/pnas.61.1.46. View